Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structome-TM: complementing dataset assembly for structural phylogenetics by addressing size-based biases.

Bioinformatics advances·2026
Same author

SGGly: a web server for whole-protein, structure-guided analysis of candidate N-linked glycosylation sites.

Nucleic acids research·2026
Same author

A three generation family with VACTERL association is found to have a rare form of diamond-blackfan anaemia.

European journal of human genetics : EJHG·2026
Same author

Systematic evaluation of computational tools to predict the effects of mutations on protein-ligand binding affinity in the absence of experimental structures.

Briefings in bioinformatics·2026
Same author

Structome-AlignViewer: On Confidence Assessment in Structure-Aware Alignments.

Genome biology and evolution·2026
Same author

kinCSM-RTK: Machine Learning-Based Screening of Receptor Tyrosine Kinase Inhibitors in Drug Discovery.

Journal of chemical information and modeling·2025
Same journal

RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n - 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. <i>Pharmaceutics</i> 2022, <i>14</i>, 1322.

Pharmaceutics·2026
Same journal

Correction: Mohite et al. Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review. <i>Pharmaceutics</i> 2025, <i>17</i>, 855.

Pharmaceutics·2026
Same journal

Metal Nanoparticle-Reinforced Hydrogels Applied in the Inhibition of Clinical Pathogens: Structural Features, Mechanisms, and Biomedical Prospects.

Pharmaceutics·2026
Same journal

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations.

Pharmaceutics·2026
Same journal

Artificial Intelligence in Nanopharmaceutical Development: From Predictive Design to Clinical Translation.

Pharmaceutics·2026
Same journal

Textilinin-1, a Snake Venom-Derived Kunitz-Type Protease Inhibitor, Accelerates Wound Healing Through Anti-Inflammatory, Antibacterial, and Pro-Regenerative Activities.

Pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Aug 8, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K

CSM-Toxin: A Web-Server for Predicting Protein Toxicity.

Vladimir Morozov1,2, Carlos H M Rodrigues1,2, David B Ascher1,2

  • 1School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, QLD 4072, Australia.

Pharmaceutics
|February 25, 2023
PubMed
Summary
This summary is machine-generated.

Scientists developed CSM-Toxin, a new tool predicting biologic drug toxicity from protein sequences. This computational method helps reduce failures in biologic drug development by identifying potential toxic properties early.

Keywords:
deep-learningprotein toxicitysequence

More Related Videos

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.3K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

68.8K

Related Experiment Videos

Last Updated: Aug 8, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.3K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

68.8K

Area of Science:

  • Biochemistry
  • Computational Biology
  • Drug Development

Background:

  • Biologics are a growing therapeutic class but can exhibit toxicity.
  • Early toxicity identification in small molecules reduced clinical trial failures.
  • Predictive tools for peptide and protein toxicity are currently lacking.

Purpose of the Study:

  • To develop a computational tool for predicting peptide and protein toxicity.
  • To address the need for robust predictive models in biologic drug development.

Main Methods:

  • Curated the largest dataset of experimental peptide and protein toxicity data.
  • Developed CSM-Toxin, an in-silico toxicity classifier using deep learning and natural language processing on primary protein sequences.
  • Treated protein residues as words and sequences as sentences to encode biological language.

Main Results:

  • CSM-Toxin accurately identified potentially toxic peptides and proteins.
  • Achieved a Matthews Correlation Coefficient (MCC) of up to 0.66 in cross-validation and blind tests.
  • Outperformed existing methods, demonstrating robust and generalizable performance.

Conclusions:

  • CSM-Toxin is a valuable tool for minimizing toxicity in the biologic development pipeline.
  • The model's performance highlights its potential to improve drug safety and reduce trial failures.
  • The CSM-Toxin method is accessible via a free webserver.